bluebird bio, Inc.
BCMA CHIMERIC ANTIGEN RECEPTORS
Last updated:
Abstract:
The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
Status:
Application
Type:
Utility
Filling date:
3 Jul 2019
Issue date:
26 Dec 2019